Repligen | RGEN - Ativo Circulante





Ativo Circulante Alterar Data
Agilent USD 4.62B 21M 2025-12
Align Technology USD 2.62B 82.47M 2025-12
Bio Techne USD 637.43M 27.92M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Bruker USD 2.21B 138.1M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Danaher USD 12.76B 3.15B 2025-12
Dentsply International USD 2.02B 49M 2025-12
General Electric Aerospace USD 40.6B 522M 2025-12
Henry Schein USD 4.46B 69M 2025-12
Illumina USD 3.29B 493M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Myriad Genetics USD 332.6M 12.2M 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Pacific Biosciences Of California USD 375.05M 19.18M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Repligen USD 1.14B 40.9M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Standard Biotools USD 454.26M 18.18M 2025-12
Thermo Fisher Scientific USD 28.71B 6.41B 2025-12
Waters USD 1.99B 69.86M 2025-12
West Pharmaceutical Services USD 1.98B 154.9M 2025-12